We compared 50 patients with normal liver tissue with 168 stage 1, 84 stage 2, 82 stage 3, and 6 stage 4 LIHC patients: MAP2K1/3 were low expressed in all tumor stages (P < .05, Fig. 5A and C). Here, MAP2K1 is linked to neoplasm.